Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) EBT (2016 - 2025)

Historic EBT for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $470.6 million.

  • Fresenius Medical Care AG's EBT rose 1261.62% to $470.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 23.35%. This contributed to the annual value of $1.1 billion for FY2024, which is 162.48% up from last year.
  • Per Fresenius Medical Care AG's latest filing, its EBT stood at $470.6 million for Q3 2025, which was up 1261.62% from $396.2 million recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's EBT peaked at $515.3 million during Q3 2021, and registered a low of $171.6 million during Q1 2024.
  • In the last 5 years, Fresenius Medical Care AG's EBT had a median value of $365.6 million in 2024 and averaged $343.9 million.
  • Over the last 5 years, Fresenius Medical Care AG's EBT had its largest YoY gain of 6300.38% in 2024, and its largest YoY loss of 4816.96% in 2024.
  • Fresenius Medical Care AG's EBT (Quarter) stood at $437.0 million in 2021, then crashed by 35.33% to $282.6 million in 2022, then soared by 30.59% to $369.0 million in 2023, then tumbled by 48.17% to $191.3 million in 2024, then skyrocketed by 146.04% to $470.6 million in 2025.
  • Its EBT stands at $470.6 million for Q3 2025, versus $396.2 million for Q2 2025 and $263.0 million for Q1 2025.